US2017281527A1PendingUtilityA1
Mineral based compositions and use thereof
Est. expirySep 23, 2034(~8.2 yrs left)· nominal 20-yr term from priority
Inventors:Raziel Ronen
A61P 35/00A61K 33/04A61K 8/922A61K 8/965A61P 17/16A61K 8/671A61K 8/36A61K 8/25A61K 33/30A61K 8/97A61P 17/00A61K 8/19A61K 8/23A61K 8/678A61K 8/27A61K 8/4946A61Q 17/04A61K 31/4166
23
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Mineral-based composition and methods of use thereof in preventing skin damages, such as in subjects exposed to radiation, are provided.
Claims
exact text as granted — not AI-modified1 . A hypotonic composition having a pH of less than 7, the composition comprises:
(i) an allantoin; (ii) selenium (Se) and zinc (Zn); and (iii) a carrier.
2 . The composition of claim 1 , further comprising a plurality of minerals comprising potassium (K), calcium (Ca), magnesium (Mg), sulfate (SO4), bromide (Br), manganese (Mn), copper (Cu), sulfur (S), tellurium (Te), iron (Fe), sodium (Na) of less than 1000 mg/l and chloride of less than 500 mg/l, silica (SiO2) and bicarbonate.
3 . The composition of claim 1 , wherein said selenium (Se) has a concentration of 40-1000 mg/l, and said zinc (Zn) has a concentration of 4-1000 mg/l.
4 . The composition of claim 1 , comprising said allantoin in an amount of 0.1-5% by weight.
5 . The composition of claim 2 , comprising said plurality of minerals in an amount of 0.001-5% by weight.
6 . The composition of claim 1 having a pH in the range of 5-7.
7 . The composition of claim 2 , wherein the sodium levels are less than 500 mg/l.
8 . The composition of claim 2 , wherein the chloride levels are less than 150 mg/l.
9 . The composition of claim 2 , wherein said plurality of minerals consists of 50-500 mg/l of sodium, 25000-40000 mg/l potassium, 5000-120000 mg/l calcium, 20000-30000 mg/l magnesium, 50-150 mg/l chloride, 2000-2500 mg/l sulfate, 85-100 mg/l bromide, 5-70 mg/l manganese, 10-50 mg/l copper, 3-80 mg/l sulfur, 5-50 mg/l silica, 10-800 mg/l bicarbonate and 0.05-0.5 mg/l tellurium.
10 . The composition according to claim 1 , wherein the carrier is selected from the group consisting of jojoba oil, coconut oil, aloe vera gel, cocoa butter, lecithin, almond oil, borage oil, canola oil, grape seed oil, olive oil, soybean oil, sunflower oil, wheat germ oil, apricot kernel oil, carrot oil, mango butter, evening primrose oil, black currant oil, avocado oil, macrocrystalline wax, paraffin, petrolatum, ozokerite, montan wax, beeswax, lanolin or a derivative, candelilla wax, ouricury wax, carnauba wax, Japan wax, cocoa butter, sugarcane wax, cork fiber wax, and mixtures thereof.
11 . The composition according to claim 1 , wherein the carrier is selected from jojoba oil, coconut oil, aloe vera gel, and mixtures thereof.
12 . The composition of claim 1 , further comprising a compound selected from the group consisting of vitamin E, vitamin A, benzoic acid, benzyl alcohol, cetyl alcohol, citric acid, glycerin, imidazolidinyl urea, isopropyl myristate, methylisothiazolinone, shea butter, sorbitan tristearate and derivatives or combinations thereof.
13 . The composition of claim 1 , wherein the composition is in the form of a cream, an ointment, a gel, lotion, liniment, paste or an emulsion.
14 . The composition of claim 1 , formulated as a topical composition.
15 . The composition of claim 1 , for preventing or reducing damage to skin of a subject undergoing radiotherapy or laser treatment.
16 . The composition of claim 1 , for preventing or reducing skin cancer occurrence or reoccurrence.
17 . A method of preventing or reducing skin damage in a subject in need thereof, the method comprises:
topically applying to the skin of the subject an effective amount of a hypotonic composition having a pH of less than 7 and comprising: (i) an allantoin; (ii) selenium (Se) and zinc (Zn); and (iii) a carrier.
18 . The method of claim 17 , wherein said skin damage is caused by exposure to radiation or laser.
19 . The method of claim 17 , wherein said subject is undergoing radiotherapy.
20 . The method of claim 19 , wherein said radiotherapy is external-beam radiation therapy.
21 . The method of claim 17 , for preventing skin cancer occurrence or reoccurrence.
22 . The method of claim 17 , wherein said composition is adsorbed to the skin of the subject prior to said radiotherapy.
23 . A process for preparing a topical formulation comprising the steps of:
(i) providing a mineral-based compositions comprising selenium (Se) and zinc (Zn); (ii) mixing said mineral-based composition with a carrier at a temperature less than 10° C.; and (iii) mixing the composition of step (ii) with at least one additional ingredient selected from vitamin E, vitamin A, aloe-vera leaf and allantoin at a temperature less than 10° C.
24 . The process of claim 23 wherein said aloe-vera leaf and allantoin are mixed together at a temperature less than 10° C. prior to step (iii).
25 . The process of claim 23 , wherein said temperature less than 10° C. is about 5° C.
26 . The process of claim 23 , wherein said mixing is homogenizing.
27 . The process of claim 23 , wherein said providing the mineral based composition comprises partially desalinating mineral water.
28 . The process of claim 23 , wherein said formulation has a pH level in the range of 5-7.
29 . The process of claim 28 , wherein said lowering pH level is by adding citric acid or a derivative thereof to the mineral-based composition of (i).Join the waitlist — get patent alerts
Track US2017281527A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.